Publication

Article

Cardiology Review® Online

November 2007
Volume24
Issue 11

An elderly man at risk for embolic stroke

A 76-year-old man sought follow-up care after his primary care provider retired.

A 76-year-old man sought follow-up care after his primary care provider retired. The patient considered himself to be healthy, performed activities of daily living independently, had had no falls, and walked 1 to 3 miles daily without difficulty. He had a 5-year history of well-controlled type 2 diabetes mellitus, which was being treated with a single oral agent, and a 10-year history of hypertension, which was being treated with a low-dose diuretic and an angiotensin-converting enzyme inhibitor. The patient had been told that he had had an irregular pulse rate for 1 to 2 years, but he was unaware of any symptoms. A review of systems was otherwise normal.

On examination, the patient's body mass index was 27 kg/m2, his blood pressure was 130/70 mm Hg, and his pulse was 90 beats/minute and irregularly irregular. The remainder of the examination, including the cardiovascular exam, was normal. The complete blood count and multiphasic lab panels were normal, and the patient's glycosylated hemoglobin was 7.5%. An electrocardiogram showed atrial fibrillation at a rate of 90 to 96 beats/minute. A review of old records showed that atrial fibrillation was present on an electrocardiogram performed 1 year earlier. In addition to a rate control agent, should this patient be treated with warfarin?

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
© 2024 MJH Life Sciences

All rights reserved.